Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ethanolamine kinase 2 (ETNK2) is an enzyme belonging to the choline/ethanolamine kinase family, highly specific for the phosphorylation of ethanolamine. It catalyzes the first committed step of the CDP-ethanolamine pathway crucial for phosphatidylethanolamine synthesis, which is a key component of cellular membranes. ETNK2 displays tissue-specific expression, notably abundant in renal tubules and seminiferous ducts. Its function has been linked to cell proliferation and apoptosis in cancer, and to vascular hemostasis via modulation of fibrinolytic factors. Context-dependent roles have been reported in various cancers, sometimes acting as a tumor suppressor (as in prostate cancer) or being upregulated and promoting oncogenesis (as in gastric and thyroid cancers). Loss or downregulation of ETNK2 affects PE biosynthesis, with implications for embryogenesis and placental function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ethanolamine kinase 2 (ETNK2).